Kite Konnect
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.kitekonnect.comRevenue
$10.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Kite Konnect
Kite Konnect is a resource sponsored by Kite Pharma, dedicated to supporting healthcare providers and patients throughout the treatment journey with Kite therapy. The platform offers assistance for patient enrollment, logistical support, and additional resources for both treating and referring providers. It also provides a directory of independent support programs for patients and caregivers, covering various needs such as housing and transportation. Kite Konnect aims to facilitate a seamless experience for healthcare providers and their patients in the realm of cell therapy.Explore more
Popular SearchesKite Pharma IncKite KonnectYescartaSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kite Konnect your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Kite Konnect has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Kite Konnect
Kite Konnect, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Kite Konnect recently announced quarterly report
Check out if Kite Konnect is spiking on competitors!
Product Launch: Get notified when Kite Konnect launches new products
Funding: Get notified immidiatlly once Kite Konnect has new funding data
Click to see if Kite Konnect had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Kite Konnect as Masked Content
Find 2 more new buyers
Compare Similar Companies to Kite Konnect
Compare insights from companies similar to Kite Konnect, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Kite Konnect
$10.4M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Kite Konnect is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kite Konnect is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kite Konnect.
Kite Konnect Tech Stack
A closer look at the technologies used by Kite Konnect
Kite Konnect News & Media
Gilead and Kite Oncology Demonstrate Growing Hematology Pipeline and Strength of Leading Cell Therapy Portfolio at EHA
FOSTER CITY, Calif. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, will present 17 abstracts from its industry-leading cell therapy portfolio and growing blood cancer pipeline at the upcoming 2023 European Hematology Association (EHA) Annual Congress being held in Frankfurt, Germany, June 8-11, and virtually June 14-15. Real-World Evidence and Multi-Year Follow-Up of Pivotal Studies Reinforce Confidence in CAR T Four real-world evidenceU.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma
SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tecartus™ (brexucabtagene autoleucel, formerly KTE-X19), the first and only approved chimeric antigen receptor (CAR) T cell therapy for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). The approval of this one-time therapy follows a priority review and FDA Breakthrough Therapy Des
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Kite Konnect
Sign Up For FreeTo access detailed company insights
Kite Konnect is a resource sponsored by Kite Pharma, dedicated to supporting healthcare providers and patients throughout the treatment journey with Kite therapy. The platform offers assistance for patient enrollment, logistical support, and additional resources for both treating and referring providers. It also provides a directory of independent... Read More
